Max Healthcare, Evex Hospitals sign agreement to set up BMT program in Tbilisi

New Delhi: Max Healthcare (MHC) announced that it has entered into an agreement with Evex Hospitals to set up a Bone Marrow Transplant (BMT) program at two of its hospitals in Tbilisi, Georgia. This agreement involves setting up a fully functional adult BMT program at the Caucasian Medical Centre (CMC), Tbilisi and a pediatric BMT program at Iashvili Children’s Central Hospital, which are a part of the Evex Hospitals.

This agreement will be executed over the next 18 months. MHC will be working closely with the Evex teams during this period, and advising Evex Hospitals on the layout of the facilities needed at their hospitals, establishing clinical protocols for BMT, equipment planning at the associated blood banks and super-specialised lab, and sourcing the medicines needed for conducting BMTs. The Evex clinical teams will also undergo extensive training at MHC facilities in Delhi. A team of doctors, nurses and technicians will be undergoing three to six months of hands-on training starting in January 2023.

The program will be led by Dr Esha Kaul, Associate Director, Medical Oncology (Haematology, Hemato-Oncology, BMT), Max Super Speciality Hospital. Under the proposed partnership, both firms envision providing quality healthcare services to patients across the Central Asian region. Presently most of the patients from Georgia travel to other countries such as Turkey and Germany, which is expensive as well as inconvenient. This program will significantly reduce the costs for the patients.

Commenting on the program, Anas Abdul Wajid, Senior Director and Chief Sales and Marketing Officer, Max Healthcare, said, “We believe our partnership will bring huge benefits to the citizens of Georgia, who will be able to access world-class healthcare services in their home country and at a fraction of the present costs abroad. We are encouraged by the government’s ‘Heal in India’ initiatives to boost value medical travel”.